| name | es-outpatient-hypoglycemia-risk-assessment |
| description | Assesses outpatient diabetes patients for high hypoglycemia risk using Table 1 criteria including medications, organ function, age, and history. Triggered by questions such as "Is this outpatient diabetic patient at high risk for hypoglycemia?" or "Should I consider preventive hypoglycemia interventions?" |
Outpatient Hypoglycemia Risk Assessment
STEP 1 — Gather Information
Collect medication list (insulin, sulfonylureas, meglitinides), assess renal and hepatic function, age, history of severe hypoglycemia, impaired awareness of hypoglycemia, cognitive impairment, diabetes duration, alcohol use, eating disorders, irregular eating patterns, fasting practices, and endocrine insufficiency.
STEP 2 — Rule In / Rule Out
Determine if any Table 1 high‑risk criterion is present. If yes → proceed to classification; if no → classify as low risk.
STEP 3 — Classify or Stratify
Classify patient as high risk for hypoglycemia if at least one criterion from Table 1 is met; otherwise classify as low risk.
STEP 4 — Decide
If high risk, initiate preventive interventions (e.g., real‑time CGM, structured diabetes education, ensure glucagon availability). If low risk, continue routine monitoring and standard education.
Clinical Guardrails / Mimics / Pitfalls
Do not rely solely on age; impaired awareness of hypoglycemia often requires specific questioning. Avoid assuming low risk in sulfonylurea users without checking renal function. Consider transient risks such as illness, fasting, or medication changes. Do not overlook cognitive impairment or alcohol use as contributors.
Concrete Clinical Example
A 70‑year‑old woman with type 2 diabetes on glimepiride and basal insulin, eGFR 45 mL/min/1.73 m², reports occasional confusion during low glucose episodes → meets medication + renal dysfunction + impaired awareness → high risk → initiate real‑time CGM and structured education.
Source: Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2023, https://doi.org/10.1210/clinem/dgac596
